Blood Pressure Drug Recall Over Cancer Risk

Over 500,000 bottles of a popular blood pressure medication have been recalled after the discovery of a potentially cancer-causing chemical impurity. The FDA announced the recall, which affects patients in states including Iowa, Illinois, and Wisconsin. Drugmaker Teva is responsible for the recall, highlighting potential safety risks in older generic drugs. Consumers are advised to consult healthcare providers for alternatives as the situation develops.